AGP Executive Report
Last update: 6 hours agoRespiratory Illness: Germany estimates around six million new respiratory illnesses as flu activity rises and COVID levels in wastewater increase. Leukaemia Research: A study found azacitidine, a long-used blood cancer drug, appears to kill many cancer cells by acting on RNA rather than DNA—potentially pointing to a more precise treatment target. Care and Industry: Nursing-care reform is raising concerns among caregivers in Germany, while Jacobs has been selected to deliver a new Sanofi insulin manufacturing facility in the country. Medical Technology: MEDICA 2026 in Düsseldorf put innovations for the “hospital of the future” in the spotlight.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.